Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration
NCT ID: NCT05297422
Last Updated: 2022-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
81 participants
INTERVENTIONAL
2022-01-20
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supraclavicular Brachial Plexus Block During Upper Limb Surgeries
NCT05315271
Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries
NCT04933149
Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block
NCT04508894
Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery
NCT02713230
The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction
NCT01716078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Axillary Approach to Brachial Plexus Blockade will be performed using 30ml Ropivacaine 0.5% ,without Ketamine as an adjuvant.
Forearm surgey
Microsurgery Clinic , KAT Hospital Athens
Ropivacaine
Ropivacaine
Ketamine IV
Axillary Approach to Brachial Plexus Blockade will be performed using 30ml Ropivacaine 0.5% ,with Ketamine as an adjuvant 30mg intravenously.
Forearm surgey
Microsurgery Clinic , KAT Hospital Athens
Ropivacaine
Ropivacaine
Ketamine
Ketamine
Ketamine Regional
Axillary Approach to Brachial Plexus Blockade will be performed using 30ml Ropivacaine 0.5% ,with Ketamine as an adjuvant 30mg regionally.
Forearm surgey
Microsurgery Clinic , KAT Hospital Athens
Ropivacaine
Ropivacaine
Ketamine
Ketamine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Forearm surgey
Microsurgery Clinic , KAT Hospital Athens
Ropivacaine
Ropivacaine
Ketamine
Ketamine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA score I, II, III
Exclusion Criteria
* Peripheral neuropathy
* Severe hepatic or renal disease
* Gastrointestinal bleeding history
16 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National and Kapodistrian University of Athens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Demetra Solomou
Anaesthesiology Resident at KAT and Masters Student at National and Kapodistrian University of Athens
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodoros Xanthos, Professor
Role: STUDY_DIRECTOR
National Kapodistrian University of Athens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National and Kapodistrian University of Athens
Athens, Attica, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
877/14-01-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.